Medicines, 2022
Shortlist up to four to read them side by side.
1,349 medicine recalls FDA’s Enforcement Report published in 2022, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
1,349of 1,349 medicine recallsshown with your filters
The list
- Medicine recall Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle Failed Dissolution Specifications; during long term stability testing. Class IIFDA’s classApr 6, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 6, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle Failed Dissolution Specifications; during long term stability testing. Class IIFDA’s classApr 6, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 6, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Meclizine Hydrochloride Tablets USP, 12.5 mg Labeling: Label mix-up: Incorrect label placed on product. FDA Class I, its most serious class Class IFDA’s class (needs attention)Apr 6, 2022in FDA’s Enforcement Report5 statesnamed in where it went PublishedApr 6, 2022ClassClass IStatusTerminatedWhereArkansas, Florida, North Carolina, Ohio and South Carolina
- Medicine recall REVITADERM WOUND CARE GEL, (Benzalkonium Chloride in a gel containing transforming growth factor-b), 0.1% Microbial Contamination of Non-sterile Product; FDA analysis found the product to be contaminated with Bacillus cereus. FDA Class I, its most serious class Class IFDA’s class (needs attention)Mar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMar 30, 2022ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Betamethasone Dipropionate Lotion USP, 0.05%* (Augmented) cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Clobetasol Propionate Cream USP, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Clobetasol Propionate Cream USP, 0.05% (Emollient) cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Clobetasol Propionate Lotion, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Clobetasol Propionate Ointment USP, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Clobetasol Propionate Gel, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Desonide Ointment, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Desoximetasone Ointment USP, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Desoximetasone Ointment USP, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Desoximetasone Ointment USP, 0.25% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Diclofenac Sodium Topical Solution USP, 1.5% w/w, 5 fl cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Diclofenac Sodium Topical Solution USP, 1.5% w/w, 5 fl cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Diflorasone Diacetate Ointment USP, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Econazole Nitrate Cream, 1% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Fluocinonide Cream USP, 0.1%, 120 grams tube cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Fluocinonide Gel USP, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Fluocinonide Topical Solution USP, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Gentamicin Sulfate Cream USP, 0.1% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Gentamicin Sulfate Ointment USP 0.1% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Halobetasol Propionate Ointment, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Halobetasol Propionate Ointment, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Hydrocortisone Butyrate Lotion 0.1%, 4 fl cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Halobetasol Propionate Ointment, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Hydrocortisone Butyrate Lotion, 0.1% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Lidocaine Cream, 4% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Lidocaine Ointment USP, 5% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Nystatin and Triamcinolone Acetonide Ointment, USP cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Triamcinolone Acetonide Ointment USP, 0.5% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Triamcinolone Acetonide Cream USP, 0.1% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Triamcinolone Acetonide Lotion USP, 0.025%, 60 mL cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Triamcinolone Acetonide Ointment USP, 0.1% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Clobetasol Propionate Cream USP, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Diflorasone Diacetate Ointment USP, 0.05% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Gentamicin Sulfate Cream USP, 0.1% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Hydrocortisone Butyrate Lotion, 0.1%, 4 fl oz cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Lidocaine Cream 4% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Lidocaine Ointment USP, 5% cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Norepinephrine Bitartrate Injection 4mg per 250 mL Defective container Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Norepinephrine Bitartrate Injection 16 mg per 250 mL added to 0.9% Sodium Chloride, 16 mg, 250 mL excel bag Defective container Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Norepinephrine Bitartrate Injection 8 mg per 250 mL Defective container Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Phenylephrine HCl Injection 40 mg per 250 mL Defective container Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Phenylephrine HCl Injection 50 mg per 250 mL Defective container Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Phenylephrine HCl Injection Defective container Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Epinephrine Injection 8 mg per 250 mL Defective container Class IIFDA’s classMar 30, 2022in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMar 30, 2022ClassClass IIStatusTerminatedWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.